xMas Holidays
Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Dermapharm Holding SE: A reportable insider transaction was published on 11th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 11th November 2024,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg 
. The transaction toke place on 8th November 2024. The order was executed at the trading place Deutsche Börse - Frankfurt Xetra. . The aggregated volume was 95.185,00 EUR, based on an average price of 31,73 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 27th June 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th June 2023,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 23rd June 2023. The order was executed at the trading place Frankfurt. . The aggregated volume was 99.902,36 EUR, based on an average price of 44,96 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 14th October 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th October 2022,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 14th October 2022. The order was executed at the trading place Frankfurt. . The aggregated volume was 98.900,00 EUR, based on an average price of 39,56 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.